Small animal models of kidney disease: A review

Methods in Molecular Biology

Volumn 466, Issue , 2009, Pages 41-57

  Hewitson, Tim D ^a,b   Ono, Takahiko ^c   Becker, Gavin J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Animal models; Kidney disease; Nephrotoxins; Progression

Indexed keywords

ANIMALIA;

EID: 60349103148     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-352-3_4     Document Type: Review

References (54)

1. De Heer, E. and Bruijn, J. A. (1996) Advantages and shortcomings of experimental models of immune-mediated glomerular and tubulointerstitial diseases. Exp. Nephrol. 4, 193-200.
2. Furness, P. N. and Harris, K. (1994) An evaluation of experimental models of glomerulonephritis. Int. J. Exp. Pathol. 75, 9-22.
3. Rees, D. A. and Alcolado, J. C. (2005) Animal models of diabetes mellitus. Diabet. Med. 22, 359-370.
4. Wei, Q., Wang, M. H., and Dong, Z. (2005) Differential gender differences in ischemic and nephrotoxic acute renal failure. Am. J. Nephrol. 25, 491-499.
5. Hewitson, T. D., Mookerjee, I., Masterson, R., Zhao, C., Tregear, G. W., Becker, G. J., and Samuel, C. S. (2007) Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology 148, 660-669.
6. Chevalier, R. L. (2006) Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2, 157-168.
7. Haralambous-Gasser, A., Chan, D., Walker, R. G., Powell, H. R., Becker, G. J., and Jones, C. L. (1993) Collagen studies in newborn rat kidneys with incomplete ureteric obstruction. Kidney Int. 44, 593-605.
8. Cochrane, A. L., Kett, M. M., Samuel, C. S., Campanale, N. V., Anderson, W. P., Hume, D. A., Little, M. H., Bertram, J. F., and Ricardo, S. D. (2005) Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J. Am. Soc. Nephrol. 16, 3623-3630.
9. Strauch, M. and Gretz, N. (1988) Animal models to induce renal failure: A historical survey. Contrib. Nephrol. 60, 1-8.
10. Eddy, A. A., Liu, E., and McCullock, L. (1998) Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int. 53, 1182-1189.
11. Molitoris, B. A. (1998) Ischemic acute renal failure: exciting times at our fingertips. Curr. Opin. Nephrol. Hypertens. 7, 405-406.
12. Azuma, H., Nadeau, K., Takada, M., and Tilney, N. L. (1997) Initial ischemia/reperfusion injury influences late functional and structural changes in the kidney. Transplant Proc. 29, 1528-1529.
13. Forbes, J. M., Jandeleit-Dahm, K., Allen, T. J., Hewitson, T. D., Becker, G. J., and Jones, C. L. (2001) Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Exp. Nephrol. 9, 309-316.
14. Bertani, T., Rocchi, G., Sachi, G., Mecca, G., and Remuzzi, G. (1986) Adriamycin-induced glomerulosclerosis in the rat. Am. J. Kid. Dis. 7, 12-19.
15. Wang, Y., Wang, Y. P, Tay, Y.-C., and Harris, D. C. H. (2000) Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events. Kidney Int. 58, 1797-1804.
16. Okuda, S., Oh, Y., Tsuruda, H., Onoyama, K., Fujimi, S., and Fujishima, M. (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 29, 502-510.
17. Javaid, B., Olson, J. L., and Meyer, T. W. (2001) Glomerular injury and tubular loss in adriamycin nephrosis. J Am Soc Nephrol 12, 1391-1400.
18. Jones, C . L., Buch, S., Post, M ., McCulloch, L ., Liu, E., and Eddy, A. A. (1992) Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am. J. Pathol. 141, 1381-1396.
19. Jones, C. L., Buch, S., Post, M., McCulloch, L., Liu, E., and Eddy, A. A. (1991) Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int. 40, 1020-1031.
20. Razzaque, M. S. (2007) Cisplatin nephropathy: is cytotoxicity avoidable? Nephrol. Dial. Transplant. 22, 2112-2116.
21. Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., McLeroy, P., Nibhanupudy, B., Li, S., and Star, R. A. (2001) Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 60, 2118-2128.
22. Lee, S., Kim, W., Moon, S. O., Sung, M. J., Kim, D. H., Kang, K. P., Jang, Y. B., Lee, J. E., Jang, K. Y., and Park, S. K. (2006) Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol. Dial. Transplant. 21, 2096-2105.
23. Yamate, J., Ishida, A., Tsujino, K., Tatsumi, M., Nakatsuji, S., Kuwamura, M., Kotani, T., and Sakuma, S. (1996) Immunohistochemical study of rat renal interstitial fibrosis induced by repeated injection of cisplatin, with special reference to the kinetics of macrophages and myofibroblasts. Toxicol. Pathol. 24, 199-206.
24. Anders, H. and Schlondorff, D. (2000) Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp. Nephrol. 8, 181-193.
25. Tanaka-Kagawa, T., Suzuki, M., Naganuma, A., Yamanka, N., and Imura, N. (1998) Strain difference in sensitivity of mice to renal toxicity of inorganic mercury. J. Phramacol. Exp. Ther. 285, 335-341.
26. Palmer, B.F., and Henrich, W.L. (2004) Toxic nephropathy. In: Brenner and Reactor's The Kidney (7th edn.), Brenner BM. Saunders, Philadelphia, PA, 1625-1658.
27. Spiegel, D. M., Shanley, P. F., and Molitoris, B. A. (1990) Mild ischemia predisposes the S3 segment to gentamicin toxicity. Kidney Int 38, 459-464.
28. Tamaki, K., Yuan, Q., Ohkawa, H., Imazeki, I., Moriguchi, Y., Imai, N., Sasaki, S., Takeda, K., and Fukagawa, M. (2006) Severe hyperparathyroidism with bone anormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 21, 651-659.
29. Minami, T., Nakagawa, H., Ichii, M., Kadota, E., and Okazaki, Y. (1994) Nephrotoxicity induced by a single dose of adenine: effects of 4-aminopyrazolo [3,4-d] pyrimidine and allopurinol. Biol. Pharm. Bull. 17, 201-206.
30. Yuan, H. T., Li, X. Z., Pitera, J. E., Long, D. A., and Woolf, A. S. (2003) Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. Am. J. Pathol. 163, 2289-2301.
31. Ishizaki, M., Masuda, Y., Fukuda, Y., Sugisaki, Y., Yamanaka, N., and Masugi, Y. (1986) Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of anti-thymocyte serum. Acta Pathol. Jpn. 36, 1191-1203.
32. Mosley, K., Collar, J., and Cattell V. (2000) Mesangial cell necrosis in Thy 1 glomerulonephritis - an ultrastructural study. Virchows Arch 436, 567-573.
33. Liu, N., Makino, T., Nogaki, F., Kusano, H., Suyama, K., Muso, E., Honda, G., Kita, T., and Ono, T. (2004) Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats. Am. J. Physiol. Renal Physiol. 287, F612-F620.
34. Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., and Savill, J. (1994) Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94, 2105-2116.
35. Wada, Y., Morioka, T., Oyanagi-Tanaka, Y., Yao, J., Suzuki, Y., Gejyo, F., Arakawa, M., and Oite, T. (2002) Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis. Kidney Int. 61, 432-443.
36. Erlich, J. H., Holdsworth, S. R., and Tipping, P. G. (1997) Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am. J. Pathol. 150, 873-880.
37. Pusey, C. D. (2003) Anti-glomerular basement membrane disease. Kidney Int. 64, 1535-1550.
38. Hellmark, T., Johansson, C., and Wieslander, J. (1994) Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int. 46, 823-829.
39. Reynolds, J., Mavromatidis, K., Cashman, S. J., Evans, D. J., and Pusey, C. D. (1998) Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat. Nephrol. Dial. Transplant. 13, 44-52.
40. Steblay, R. W. (1962) Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant. J. Exp. Med. 116, 253-272.
41. De Vriese, A. S., Endlich, K., Elger, M., Lameire, N. H., Atkins, R. C., Lan, H. Y., Rupin, A., Kriz, W., and Steinhausen, M. W. (1999) The role of selectins in glomerular leukocyte recruitment in rat anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 10, 2510-2517.
42. Xie, C., Sharma, R., Wang, H., Zhou, X. J., and Mohan, C. (2004) Strain distribution pattern of susceptibility to immune-mediated nephritis. J. Immunol. 172, 5047-5055.
43. Hisada, Y., Sugaya, T., Yamanouchi, M., Uchida, H., Fujimura, H., Sakurai, H., Fukamizu, A., and Murakami, K. (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J. Clin. Invest. 103, 627-635.
44. Reynolds, J., Albouainain, A., Duda, M. A., Evans, D. J., and Pusey, C. D. (2006) Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol. Dial. Transplant 21, 3398-3408.
45. Breyer, M. D., Bottinger, E., Brosius, IIIF. C., Coffman, T. M., Harris, R. C., Heilig, C. W., and Sharma, K. (2005) Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27-45.
46. Tesch, G. H. and Nikolic-Paterson, D. J. (2006) Recent insights into experimental mouse models of diabetic nephropathy. Nephron Exp. Nephrol. 104, e57-e62.
47. Gurley, S. B., Clare, S. E., Snow, K. P., Hu, A., Meyer, T. W., and Coffman, T. M. (2006) Impact of genetic background on nephropathy in diabetic mice. Am. J. Physiol. Renal Physiol. 290, F214-F222.
48. Magnani, M., Rossi, L., Stocchi, V., Cucchiarini, L., Piacentini, G., and Fornaini, G. (1988) Effect of age on some properties of mice erythrocytes. Mech. Ageing Dev. 42, 37-47.
49. Kelly, D. J., Wilkinson-Berka, J. L., Allen, T. J., Cooper, M. E., and Skinner, S. L. (1998) A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int. 54, 343-352.
50. Mifsud, S. A., Skinner, S. L., Cooper, M. E., Kelly, D. J., and Wilkinson-Berka, J. L. (2002) Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats. J. Am. Soc. Nephrol. 13, 684-692.
51. Martin, J., Kelly, D. J., Mifsud, S. A., Zhang, Y., Cox, A. J., See, F., Krum, H., Wilkinson-Berka, J., and Gilbert, R. E. (2005) Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. Cardiovasc. Res. 65, 694-701.
52. Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., and Tesch, G. H. (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 16, 1711-1722.
53. Stevenson, F. T., Kaysen, G. A. (1999) Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment. Wien Klin Wochenschr. 111, 307-314.
54. Bascands, J. L. and Schanstra, J. P. (2005) Obstructive nephropathy Insights from genetically engineered animals. Kidney Int. 68, 925-937.